Home › Funds › KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC › ALGN

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC position in ALGN

ALIGN TECHNOLOGY INC · Health Care

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reported holding 1,300,319 shares of ALGN (ALIGN TECHNOLOGY INC) in its Q3 2026 13F filing — a position valued at US$189.0M, representing 0.71% of its reported portfolio and ranking #50 among its reported holdings. KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC has disclosed ALGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.30M sh
Reported value held$189.00M
Portfolio Weight0.71%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC's ALGN position evolved

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC first disclosed a stake in ALGN in Q3 2023 at 11,750 shares (US$3.6M). The position peaked in Q1 2026 at 1,902,905 shares, worth US$326.2M. Across 13 filings, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,300,319 shares valued at US$189.0M — a reduction of -433,165 shares quarter over quarter.. Notable position changes include a 4391% increase in Q2 2024 (shares rose 5% over the following quarter), a 41% increase in Q2 2025 (shares fell 34% over the following quarter), a 150% increase in Q1 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.75K $3.59M New
Q4 2023 11.26K $3.09M Reduce
Q1 2024 10.87K $3.57M Reduce
Q2 2024 488.25K $117.88M Add
Q3 2024 564.49K $143.56M Add
Q4 2024 564.22K $117.65M Hold
Q1 2025 577.52K $91.75M Add
Q2 2025 815.29K $154.36M Add
Q3 2025 779.81K $97.65M Reduce
Q4 2025 760.82K $118.80M Reduce
Q1 2026 1.90M $326.22M Add
Q2 2026 1.73M $292.37M Reduce
Q3 2026 1.30M $189.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALGN and 13F data

ALGN (ALIGN TECHNOLOGY INC) is a Health Care company. 18 other funds we track also report a position in ALGN — the largest reported positions include Ninety One UK Ltd (US$310.1M), Ruane Cunniff & Goldfarb (Sequoia) (US$197.6M), JACOBS LEVY EQUITY MANAGEMENT, INC (US$180.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALGN

All ALGN fund holders →

FAQ

How long has KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC held ALGN?

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC has disclosed ALGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC's current position in ALGN?

As of Q3 2026, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 1.30M shares of ALGN (ALIGN TECHNOLOGY INC), valued at $189.00M, representing 0.71% of its reported portfolio and ranking #50.

Has KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC been buying or selling ALGN?

In the latest 13F filing (Q3 2026), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reduced its position in ALGN. The position peaked in Q1 2026 at 1.90M shares.

Which other funds hold ALGN?

Other major institutional holders of ALGN include Ninety One UK Ltd, Ruane Cunniff & Goldfarb (Sequoia), JACOBS LEVY EQUITY MANAGEMENT, INC, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.